Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009144
Filing Date
2016-11-03
Accepted
2016-11-03 07:01:35
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20160930x10q.htm 10-Q 1439313
2 EX-31.1 trvn-20160930ex3110a0314.htm EX-31.1 15612
3 EX-31.2 trvn-20160930ex3127f9de7.htm EX-31.2 14762
4 EX-32.1 trvn-20160930ex32175eb38.htm EX-32.1 10245
5 EX-32.2 trvn-20160930ex322e4c01d.htm EX-32.2 12218
  Complete submission text file 0001558370-16-009144.txt   5333411

Data Files

Seq Description Document Type Size
6 EX-101.INS trvn-20160930.xml EX-101.INS 1117722
7 EX-101.SCH trvn-20160930.xsd EX-101.SCH 29152
8 EX-101.CAL trvn-20160930_cal.xml EX-101.CAL 38633
9 EX-101.DEF trvn-20160930_def.xml EX-101.DEF 152587
10 EX-101.LAB trvn-20160930_lab.xml EX-101.LAB 348978
11 EX-101.PRE trvn-20160930_pre.xml EX-101.PRE 268880
Mailing Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406
Business Address 1018 WEST 8TH AVENUE, SUITE A KING OF PRUSSIA PA 19406 610-354-8840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 161970103
SIC: 2834 Pharmaceutical Preparations